Article
Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.
Pharmacogenetics and genomics - 1 Apr 2013
Lee Jen-Kuang, Wu Cho-Kai, Tsai Chia-Ti, Lin Lian-Yu, Lin Jou-Wei, Chien Kuo-Liong, Hwang Juey-Jen, Lin Chunn-Lee, Tseng Chuen-Den, Chiang Fu-Tien
Abstract excerpt
OBJECTIVES: The objective of this study was to examine the relationship between renin-angiotensin system genotypes and the pharmacogenetics of angiotensin-converting enzyme (ACE) inhibitors in Chinese patients with coronary artery disease (CAD). METHODS: Patients with angiographic CAD were recruited from 1995 to 2003. The baseline characteristics and genetic polymorphisms [ACE gene insertion/deletion (I/D)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
